Overview

Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)

Status:
Completed
Trial end date:
2017-03-31
Target enrollment:
Participant gender:
Summary
To investigate the risk of major bleeding (including gastrointestinal and intracranial bleeding episodes) among new users of low-dose acetylsalicylic acid (ASA) in clinical practice
Details
Lead Sponsor:
Bayer
Treatments:
Anticoagulants
Aspirin
Clopidogrel
Salicylates
Salicylic Acid